The authors present a shift toward more integrated purification processes.
Hervé Broly
Advertisement
Hervé Broly is the head of biotech process sciences and the vice president at the Center of Expertise, Merck Serono SA
Articles by Hervé Broly
Apply a DoE strategy to test several formulations in parallel.
Combine cost analyses with QbD to improve operations and lower costs.
Advertisement
Latest Updated Articles
Safe Freeze–Thaw of Protein Drug Products: A QbD ApproachDecember 1st 2010
Intensification of a Chromatography PlatformJuly 1st 2017
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Approves Roche’s Enspryng as First At-Home Subcutaneous Treatment for Thyroid Eye Disease
2
BioPharm Brief: Gene Therapy Progress, FDA Approval, and $103M Funding
3
Estuary Biotherapeutics Launches With $103 Million for ADPKD Gene Therapy
4
Opus Genetics’ OPGx-LCA5 Gene Therapy Shows Sustained Vision Gains Ahead of Phase 3
5